| related words |
| endpoint |
| predictive |
| investigator |
| bm |
| xr |
| faropenem |
| echo |
| provenge |
| technosphere |
| antibiotic |
| proquin |
| insulin |
| hemopure |
| discovering |
| receptive |
| ceplene |
| genentech |
| viaject |
| glumetza |
| biosensor |
|
| related documents |
| 789132--3/15/2010--SPECTRANETICS_CORP |
| 1145197--3/16/2009--INSULET_CORP |
| 949858--3/14/2008--SONUS_PHARMACEUTICALS_INC |
| 1159036--3/12/2010--HALOZYME_THERAPEUTICS_INC |
| 1125001--3/27/2008--IOMAI_CORP |
| 1145197--3/20/2008--INSULET_CORP |
| 1178104--9/18/2009--CARDICA_INC |
| 1123695--3/31/2008--IMARX_THERAPEUTICS_INC |
| 1005201--3/12/2008--DEPOMED_INC |
| 899460--3/16/2010--MANNKIND_CORP |
| 1281696--3/17/2008--BMP_Sunstone_CORP |
| 1340744--3/11/2008--Altus_Pharmaceuticals_Inc. |
| 1005201--3/6/2009--DEPOMED_INC |
| 1178104--9/19/2007--CARDICA_INC |
| 1104855--3/16/2007--SUPPORTSOFT_INC |
| 1178104--9/11/2008--CARDICA_INC |
| 799698--4/1/2008--CYTRX_CORP |
| 1212235--3/17/2008--XTENT_INC |
| 1145197--3/9/2010--INSULET_CORP |
| 789132--3/16/2007--SPECTRANETICS_CORP |
|
| related topics |
| {product, candidate, development} |
| {financial, litigation, operation} |
| {cost, operation, labor} |
| {interest, director, officer} |
| {stock, price, operating} |
| {cost, contract, operation} |
| {tax, income, asset} |
| {provision, law, control} |
| {acquisition, growth, future} |
| {cost, regulation, environmental} |
| {investment, property, distribution} |
| {condition, economic, financial} |
| {loan, real, estate} |
| {competitive, industry, competition} |
| {regulation, government, change} |
| {property, intellectual, protect} |
| {customer, product, revenue} |
| {capital, credit, financial} |
| {loss, insurance, financial} |
| {regulation, change, law} |
|